Aspirin alone for patients with lacunar stroke - 3
Narrator: This is NIH health matters, I’m Joe Balintfy. A recent study has enrolled more than 3,000 patients with small vessel stroke to test two interventions.
Koroshetz: One was aggressive blood pressure lowering.
Narrator: Dr. Walter Koroshetz at the NIH says blood pressure is the key risk factor for these strokes.
Koroshetz: And the other one was comparing a combination of two antiplatelet agents to aspirin alone.
Narrator: The study shows aspirin combined with the antiplatelet drug clopidogrel is no better than aspirin alone for stroke prevention in people with a history of small vessel strokes. For more on this study, and to learn more about strokes and stroke risk, visit the website stroke.nih.gov. Health Matters is produced by the National Institutes of Health, part of the U.S. Department of Health and Human Services.
About NIH Radio
NIH Radio offers free audio news programs from the National Institutes of Health, your reliable source for health information.
All NIH Radio content is in the public domain and can be used without charge or restriction provided that it is not used to misrepresent our agency nor used to suggest we endorse any private organization, product, or service.
NIH Radio is a service of the Office of Communications & Public Liaison.